| Name | Cambridge Nutritional Science |
|---|---|
| Epic | CNSL |
| Isin | GB00B1VCP282 |
| Industry | Medical Equipment and Services |
| Latest share price | 4.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £9.52 | Debt ratio | n/a |
| Shares in issue | 237.95 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -13.49 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.1 | 52-week high / low | 2.40p / 4.35p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Cambridge Nutritional Science |
|---|---|
| Address | One Fleet Place, London, United Kingdom, EC4M 7WS |
| Telephone | +44 (0)12 5976 3030 |
| Website | https://www.cnslab.co.uk/ |
| Director | Position |
|---|---|
| Mr Jeremy Millard | Non-Executive Director |
| Mr Carolyn Rand | Non-Executive Chairman |
| Mr James Cooper | Interim CEO |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/03/24 | 31/03/23 | 31/03/22 |
| Intangible asssets and goodwill | 4.1 | 4.53 | 4.75 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 6.02 | 6.11 | 7.1 |
| Inventory / work in progress | 0.61 | 0.78 | 1.09 |
| Trade and other receivables | 1.82 | 2.4 | 3.05 |
| Cash and equivalents | 2.94 | 5.12 | 1.6 |
| Other current assets and asset held for resale | 2.5 | n/a | n/a |
| Total of all assets | 13.89 | 14.4 | 17.84 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 1.45 | 1.58 | 2.97 |
| Long term liabilities | 2.53 | 2.52 | 2.57 |
| Other liabilites / pension etc | 0.24 | 0.35 | 0.47 |
| Total of all liabilities | 4.21 | 4.45 | 6.02 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 9.68 | 9.95 | 11.82 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 10.26 | 10.24 | 8.04 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -25.59 | -25.32 | -0.03 |
| Share premium account | 25.07 | 25.07 | 25.34 |
| Total equity | 9.68 | 9.95 | 11.82 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -0.77 | -3.24 | -0.93 |
| Pre-tax profit | -0.74 | -3.25 | -0.95 |